Revance Therapeutics

About:

Revance is a biotechnology company focusing on aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences.

Website: http://www.revance.com

Twitter/X: revance

Top Investors: Horizon Technology Finance, EDBI, Vivo Capital, Novaquest Capital Management, Essex Woodlands Healthcare Partners

Description:

Revance Therapeutics is a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems.